• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物(AGE)的AGE系统受体(RAGE):连接肥胖与心血管疾病的炎症途径。

The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.

作者信息

Vianello Elena, Beltrami Antonio P, Aleksova Aneta, Janjusevic Milijana, Fluca Alessandra L, Corsi Romanelli Massimiliano M, La Sala Lucia, Dozio Elena

机构信息

Department of Biomedical Sciences for Health, Università degli Studi di Milano, 20133 Milan, Italy.

Experimental Laboratory for Research on Organ Damage Biomarkers, IRCCS Istituto Auxologico Italiano, 20149 Milan, Italy.

出版信息

Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707.

DOI:10.3390/ijms26083707
PMID:40332316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12028226/
Abstract

The AGE (advanced glycation end-products)-RAGE (receptor for AGE) system is a pro-inflammatory pathway that contributes to the pathogenesis of obesity and obesity-related cardiovascular disorders (CVD). Circulating AGE and the soluble form of RAGE (sRAGE) has been suggested as a potential biomarker of CVD related to obesity. In this study, we aim to (1) summarize the current knowledge about the role of obesity in the onset and progression of CVD, (2) discuss the role of the AGE-RAGE system as a pathway promoting obesity and linking obesity to CVD, and (3) highlight available strategies for reducing AGE-RAGE system activation and the associated beneficial effects.

摘要

晚期糖基化终末产物(AGE)- 晚期糖基化终末产物受体(RAGE)系统是一条促炎途径,它在肥胖症及肥胖相关心血管疾病(CVD)的发病机制中发挥作用。循环中的AGE及RAGE的可溶性形式(sRAGE)已被认为是与肥胖相关的CVD的潜在生物标志物。在本研究中,我们旨在:(1)总结目前关于肥胖在CVD发生和发展中作用的知识;(2)讨论AGE-RAGE系统作为促进肥胖并将肥胖与CVD联系起来的途径的作用;(3)强调减少AGE-RAGE系统激活的可用策略及其相关有益效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9dd/12028226/b95a59569879/ijms-26-03707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9dd/12028226/4c2d7d15cd50/ijms-26-03707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9dd/12028226/b95a59569879/ijms-26-03707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9dd/12028226/4c2d7d15cd50/ijms-26-03707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9dd/12028226/b95a59569879/ijms-26-03707-g002.jpg

相似文献

1
The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.晚期糖基化终末产物(AGE)的AGE系统受体(RAGE):连接肥胖与心血管疾病的炎症途径。
Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707.
2
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.绝经后女性中晚期糖基化终末产物与心血管疾病的关系
Reprod Sci. 2015 Jul;22(7):774-82. doi: 10.1177/1933719114549845. Epub 2014 Sep 16.
3
Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.晚期糖基化终末产物及其受体介导的心血管疾病的治疗干预措施。
Curr Pharm Des. 2017;23(6):937-943. doi: 10.2174/1381612822666161006143032.
4
The role of sRAGE in cardiovascular diseases.可溶性晚期糖基化终产物受体(sRAGE)在心血管疾病中的作用。
Adv Clin Chem. 2023;117:53-102. doi: 10.1016/bs.acc.2023.08.005. Epub 2023 Sep 19.
5
Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?可溶性晚期糖基化终产物受体:肥胖 Zucker 大鼠心肌内脂质蓄积的保护分子?
Mediators Inflamm. 2019 Feb 28;2019:2712376. doi: 10.1155/2019/2712376. eCollection 2019.
6
Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.长寿个体中可溶性晚期糖基化终产物受体异构体和晚期糖基化终产物的调节。
Biomark Med. 2021 Aug;15(11):785-796. doi: 10.2217/bmm-2020-0856. Epub 2021 Jul 8.
7
Receptor for the Advanced Glycation End Products () Pathway in Adipose Tissue Metabolism.晚期糖基化终产物()途径在脂肪组织代谢中的受体。
Int J Mol Sci. 2023 Jul 1;24(13):10982. doi: 10.3390/ijms241310982.
8
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.衰老相关、非传染性慢性炎症性疾病中的晚期糖基化终产物及其受体;临床证据概述及对疾病的潜在贡献。
Int J Biochem Cell Biol. 2016 Dec;81(Pt B):403-418. doi: 10.1016/j.biocel.2016.06.016. Epub 2016 Jun 29.
9
Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.实验性高血糖改变健康肥胖人群循环中氧化应激和糖基化终产物的浓度及其肾清除率。
Nutrients. 2019 Mar 1;11(3):532. doi: 10.3390/nu11030532.
10
The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.RAGE/DIAPH1 轴:肥胖的中介物和人类代谢心血管疾病的拟议生物标志物。
Cardiovasc Res. 2024 Feb 17;119(18):2813-2824. doi: 10.1093/cvr/cvac175.

引用本文的文献

1
Exploring the Interplay Between Glycated Albumin, AGEs, and Inflammation in Old Patients with CKD.探索老年慢性肾脏病患者糖化白蛋白、晚期糖基化终末产物与炎症之间的相互作用
Metabolites. 2025 Aug 1;15(8):515. doi: 10.3390/metabo15080515.
2
Impact of Di-(2-Ethylhexyl)-Phthalate on Metabolic Syndrome: Insights from Network Toxicology and Molecular Docking and Dynamics.邻苯二甲酸二(2-乙基己基)酯对代谢综合征的影响:来自网络毒理学以及分子对接与动力学的见解
Diabetes Metab Syndr Obes. 2025 Jul 8;18:2277-2288. doi: 10.2147/DMSO.S523668. eCollection 2025.
3
Increasing Life Expectancy with Plant Polyphenols: Lessons from the Mediterranean and Japanese Diets.

本文引用的文献

1
An overview of obesity-related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes.肥胖相关并发症概述:将体重及其他肥胖指标与不良健康结局联系起来的流行病学证据。
Diabetes Obes Metab. 2025 Apr;27 Suppl 2(Suppl 2):3-19. doi: 10.1111/dom.16263. Epub 2025 Mar 11.
2
Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product-receptor axis.恩格列净通过阻断晚期糖基化终产物受体轴改善肥胖2型糖尿病小鼠的肾脏和代谢紊乱。
Mol Med. 2025 Mar 6;31(1):88. doi: 10.1186/s10020-025-01138-0.
3
植物多酚延长寿命:来自地中海和日本饮食的经验教训。
Molecules. 2025 Jul 7;30(13):2888. doi: 10.3390/molecules30132888.
The soluble receptor for advanced glycation end products is independently associated with systolic blood pressure values and hypertension in children.
晚期糖基化终末产物可溶性受体与儿童收缩压值及高血压独立相关。
Nutr Metab Cardiovasc Dis. 2025 Jul;35(7):103862. doi: 10.1016/j.numecd.2025.103862. Epub 2025 Jan 10.
4
AGE-RAGE Axis and Cardiovascular Diseases: Pathophysiologic Mechanisms and Prospects for Clinical Applications.衰老-晚期糖基化终末产物受体轴与心血管疾病:病理生理机制及临床应用前景
Cardiovasc Drugs Ther. 2024 Nov 5. doi: 10.1007/s10557-024-07639-0.
5
Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial.调节循环中晚期糖基化终产物水平及其对颈总动脉内膜中层厚度的影响:CORDIOPREV 随机对照试验。
Cardiovasc Diabetol. 2024 Oct 14;23(1):361. doi: 10.1186/s12933-024-02451-4.
6
Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases.脂肪组织与其他器官相互作用中的脂肪因子:对心血管代谢疾病的影响
Biomedicines. 2024 Sep 19;12(9):2129. doi: 10.3390/biomedicines12092129.
7
Generation and Accumulation of Various Advanced Glycation End-Products in Cardiomyocytes May Induce Cardiovascular Disease.心肌细胞中各种晚期糖基化终产物的产生和积累可能导致心血管疾病。
Int J Mol Sci. 2024 Jul 3;25(13):7319. doi: 10.3390/ijms25137319.
8
Lycopene in Combination with Insulin Triggers Antioxidant Defenses and Increases the Expression of Components That Detoxify Advanced Glycation Products in Kidneys of Diabetic Rats.番茄红素联合胰岛素可触发抗氧化防御机制,增加肾脏中解毒晚期糖基化终产物的成分的表达,改善糖尿病大鼠的肾脏损伤。
Nutrients. 2024 May 23;16(11):1580. doi: 10.3390/nu16111580.
9
Effectiveness of date seed on glycemia and advanced glycation end-products in type 2 diabetes: a randomized placebo-controlled trial.枸杞对 2 型糖尿病患者血糖和糖基化终产物的有效性:一项随机安慰剂对照试验。
Nutr Diabetes. 2024 Jun 1;14(1):37. doi: 10.1038/s41387-024-00287-1.
10
Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.评估在医院条件下通过适度热量限制联合身体活动治疗的肥胖患者的 EN-RAGE、sRAGE 及其异构体:cRAGE、esRAGE。
Cytokine. 2024 Aug;180:156665. doi: 10.1016/j.cyto.2024.156665. Epub 2024 Jun 1.